Recent patents and emerging therapeutics for HIV infections: a focus on protease inhibitors
{{output}}
The inclusion of protease inhibitors (PIs) in highly active antiretroviral therapy has significantly improved clinical outcomes in HIV-1-infected patients. To date, PIs are considered to be the most important therapeutic agents for the treatment of HIV infecti... ...
